Evidence map›Paper›PMID 32984296›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Enhancing the Glucose Flux of an Engineered EP-Bifido Pathway for High Poly(Hydroxybutyrate) Yield Production.

Ying Li, Zhijie Sun, Ya Xu, Yaqi Luan, Jiasheng Xu, Quanfeng Liang, Qingsheng Qi, Qian Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Characterizing lysine acetylation of glucokinase.Protein science : a publication of the Protein Society · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ying LiNational Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Zhijie SunMarine Biology Institute, Shantou University, Shantou, China.
Ya XuNational Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Yaqi LuanNational Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Jiasheng XuNational Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Quanfeng LiangNational Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Qingsheng QiNational Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Qian WangNational Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
State Key Laboratory of Microbial TechnologyShandong University · CNShantou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs the greenhouse effect becomes more serious and carbon dioxide emissions continue rise, the application prospects of carbon sequestration or carbon-saving pathways increase. Previously, we constructed an EP-bifido pathway in

resultTo optimize the EP-bifido pathway and obtain higher PHB yields, we knocked out the specific phosphoenolpyruvate phosphate transferase system (PTS) component II Cglc, encoded by

conclusionAfter optimizing RBS of

Indexed as

EP-bifido pathwayEscherichia coliglucose fluxMAGEpoly(hydroxybutyrate) yield

Identifiers

PMID32984296
PMCPMC7481327
OpenAlexW3082940447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.